Piper Sandler Upgrades Organon & Co. (OGN) to Neutral, raises PT

Piper Sandler analyst David Amsellem upgraded Organon & Co. (NYSE: OGN) from Underweight to Neutral with a price target of $14.00 (from $5.00).

For an analyst ratings summary and ratings history on Organon & Co. click here. For more ratings news on Organon & Co. click here.

Shares of Organon & Co. closed at $11.26 yesterday.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• MARA amends Texas power site purchase agreement, posts $100M deposit
• Krait Critical Minerals closes $1.22M first tranche of placement